An update on the status of HSP90 inhibitors in cancer clinical trials
Shraddha Rastogi, Abhinav Joshi, Nahoko Sato, Sunmin Lee, Min-Jung Lee, Jane B. Trepel, Len Neckers
Journal
- ISSN / E-ISSN
- — / —
- DOI
- 10.1016/j.cstres.2024.05.005 ↗
- Volume · Issue · Pages
- 29 · 4 · 519-539
- Publisher
- Springer Netherlands
- Article URL
- https://doi.org/10.1016/j.cstres.2024.05.005 ↗
- Article details
- Unverified
Publication date (each date has its type and source)
13 Jun 2024
OpenAlex publication date · source: OpenAlex
| Type | Date | Source |
|---|---|---|
| OpenAlex publication date | 13 Jun 2024 | OpenAlex |
Keywords (as given): Hsp90 inhibitors; HSP90; molecular chaperones; cancer clinical trials; combination therapy; pimitespib; nivolumab; immune checkpoint inhibitors; pharmacodynamic biomarkers; target engagement; drug toxicity; treatment resistance
HEC Status at Publication Not the journal's current status
HEC Status at PublicationConclusive
HEC status at publication
Recognized
X
Based on the recorded HEC dataset applicable to the article's publication date. Listed as X in the HEC list for 2023–24.
- Journal
- Cell Stress and Chaperones
- Publication date used
- 13 Jun 2024 (OpenAlex publication date)
- Applicable HEC period
- 2023–24 (version 1) · 01 Jul 2023 – 30 Sep 2024
- Category
- X
- Recognition status
- Recognized (OK_RECORD_FOUND)
- Source
- HJRS 2023-24 page 1369, row 9629
- Verification status
- Verified against source · last verified 23 Sep 2026
This is an automatically generated summary based on the information available on the publication date. Terms & conditions apply.